Grant name: Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
Funding organization: National Institutes of Health (NIH)
Total funding amount: Not applicable (no direct funding)
Duration: Maximum project period of one year
Primary objective: Advance non-hormonal contraceptive and reproductive health-related product development
Key stakeholders: Researchers in reproductive health, NIH, NICHD
Funding source: NIH
Funding type: Resource access award
Significance: Supports development of safe therapeutic options in contraception
Grant frequency: Recurring
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City or Township Governments
Indian/Native American Tribal Governments (both Federally Recognized and Other)
Federal Governments and Eligible Agencies
Foreign Institutions and Non-domestic components of U.S. Organizations
Organizations must complete registrations with SAM, eRA Commons, and Grants.gov prior to application submission.
PD(s)/PI(s) must have an eRA Commons account.
Non-hormonal contraceptive methods
Reproductive health-related therapies and devices
Enable IND/IDE study for preclinical candidates
Advancement of early and advanced stage preclinical compounds and devices
Experience in protein generation, crystallography, high throughput screening, and drug metabolism
No direct funding associated with X01 resource access awards
No budget limitations specified
Application due dates: October 3, 2023; April 3, 2024; October 3, 2024; April 3, 2025; October 3, 2025; April 3, 2026
Adherence to NIH Grants Policy Statement
Compliance with data sharing and intellectual property policies
Applications must follow the SF424 (R&R) Application Guide
Letter of intent is encouraged but not required
Applications will not undergo standard peer review but will be evaluated by NIH staff
More than one X01 request per applicant can be submitted per cycle
This is a reissue of PAR-19-261, indicating ongoing interest in reproductive health research